North American Coral Snake Antivenin (Equine) (Wyeth Pharmaceuticals Inc., a subsidiary of Pfizer Inc.)
Welcome to the PulseAid listing for the North American Coral Snake Antivenin (Equine) drug offered from Wyeth Pharmaceuticals Inc., a subsidiary of Pfizer Inc.. This pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Wyeth Pharmaceuticals Inc., a subsidiary of Pfizer Inc. |
| NON-PROPRIETARY NAME: | Coral Snake (Micrurus Fulvius) Immune Globulin Antivenin (Equine) |
| SUBSTANCE NAME: | CORAL SNAKE (MICRURUS FULVIUS) IMMUNE GLOBULIN ANTIVENIN (EQUINE) |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | |
| ROUTE: | INTRAVENOUS |
| DOSAGE FORM: | INJECTION, POWDER, FOR SOLUTION |
| MARKETING CATEGORY NAME: | BLA |
| START MARKETING DATE: | 2016-10-12 |
| END MARKETING DATE: | 0000-00-00 |
North American Coral Snake Antivenin (Equine) HUMAN PRESCRIPTION DRUG Details:
| Item Description | North American Coral Snake Antivenin (Equine) from Wyeth Pharmaceuticals Inc., a subsidiary of Pfizer Inc. |
| LABELER NAME: | Wyeth Pharmaceuticals Inc., a subsidiary of Pfizer Inc. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 250([arb’U]/10mL) |
| START MARKETING DATE: | 2016-10-12 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 0008-0423_da5f96b0-5d06-4975-a2db-4e1c989385e0 |
| PRODUCT NDC: | 0008-0423 |
| APPLICATION NUMBER: | BLA101099 |
Other CORAL SNAKE (MICRURUS FULVIUS) IMMUNE GLOBULIN ANTIVENIN (EQUINE) Pharmaceutical Manufacturers / Labelers:
